Maria A Oquendo Selected Research

Major Depressive Disorder (Major Depressive Disorders)

1/2023	Brain serotonin 1A receptor binding: relationship to peripheral blood DNA methylation, recent life stress and childhood adversity in unmedicated major depression.
10/2022	Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response.
1/2022	Serotonin transporter binding in major depressive disorder: impact of serotonin system anatomy.
11/2021	Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography.
1/2021	Large-scale network dynamics in neural response to emotionally negative stimuli linked to serotonin 1A binding in major depressive disorder.
1/2021	Relationships between inflammatory markers and suicide risk status in major depression.
10/2020	Pretreatment Reward Sensitivity and Frontostriatal Resting-State Functional Connectivity Are Associated With Response to Bupropion After Sertraline Nonresponse.
10/2019	Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.
1/2019	Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.
1/2019	Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria A Oquendo Research Topics

Disease

52	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 05/2003
18	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 05/2003
13	Mood Disorders (Mood Disorder) 05/2016 - 08/2004
7	Mental Disorders (Mental Disorder) 01/2023 - 07/2005
7	Alcoholism (Alcohol Abuse) 01/2016 - 01/2003
5	Substance-Related Disorders (Drug Abuse) 01/2017 - 01/2003
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2013 - 10/2004
3	Borderline Personality Disorder (Personality Disorders, Borderline) 07/2023 - 03/2009
3	Anxiety Disorders (Anxiety Disorder) 07/2013 - 12/2004
3	Depressive Disorder (Melancholia) 03/2009 - 05/2003
2	Inflammation (Inflammations) 01/2021 - 01/2016
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 12/2004
2	Mania (Manias) 01/2018 - 10/2012
2	Personality Disorders (Personality Disorder) 01/2017 - 05/2012
2	Narcissistic Personality Disorder 01/2017 - 11/2009
2	Syndrome (Syndromes) 09/2013 - 04/2005
2	Brain Diseases (Brain Disorder) 03/2013 - 03/2009
2	Wounds and Injuries (Trauma) 03/2010 - 06/2009
1	COVID-19 09/2022
1	Spontaneous Abortion (Miscarriage) 01/2021
1	Lyme Disease (Disease, Lyme) 06/2019
1	Genetic Risk Score 12/2018
1	Neuroinflammatory Diseases 01/2018
1	Sudden Death 04/2016
1	Anhedonia 09/2015
1	Disease Susceptibility (Diathesis) 12/2014

Drug/Important Bio-Agent (IBA)

17	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 11/2004
15	Antidepressive Agents (Antidepressants)IBA 10/2022 - 07/2003
9	3,4-methylenedioxyethamphetamine (MDEA)IBA 07/2023 - 09/2003
9	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2022 - 01/2006
7	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2020 - 11/2004
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2019 - 01/2011
6	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2019 - 08/2009
6	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 10/2004
5	5-HT1A Serotonin ReceptorIBA 01/2023 - 11/2013
5	EmbarcIBA 10/2022 - 09/2015
4	Eicosapentaenoic AcidIBA 01/2021 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 11/2018 - 03/2013
3	Sertraline (Zoloft)FDA LinkGeneric 10/2022 - 01/2019
3	Testosterone (Sustanon)FDA Link 01/2022 - 10/2012
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 03/2014
3	Arachidonic Acid (Vitamin F)IBA 01/2021 - 03/2014
3	Docosahexaenoic AcidsIBA 01/2021 - 03/2014
3	Ketamine FDA LinkGeneric 12/2018 - 01/2017
3	AutoreceptorsIBA 01/2018 - 03/2013
3	Neurotransmitter Agents (Neurotransmitter)IBA 04/2016 - 04/2005
3	FenfluramineIBA 03/2014 - 05/2003
3	Glucose (Dextrose)FDA LinkGeneric 09/2007 - 11/2004
3	Dexamethasone (Maxidex)FDA LinkGeneric 08/2006 - 10/2004
2	Midazolam (Versed)FDA LinkGeneric 01/2018 - 01/2017
2	gamma-Aminobutyric Acid (GABA)IBA 04/2016 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2009
2	ProlactinIBA 03/2014 - 05/2003
2	Dopamine (Intropin)FDA LinkGeneric 09/2013 - 10/2006
2	Paroxetine (Paxil)FDA LinkGeneric 09/2013 - 07/2005
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2013 - 10/2006
2	Tryptophan HydroxylaseIBA 02/2012 - 03/2009
2	Monoamine Oxidase (MAO)IBA 06/2009 - 08/2004
2	AcidsIBA 10/2006 - 08/2006
2	Homovanillic AcidIBA 03/2005 - 09/2003
1	telomerase RNA (bTR)IBA 01/2023
1	CobaltIBA 09/2022
1	GR 89696IBA 11/2021
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 11/2021
1	docosahexaenoylascorbic acid (DHA-As)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 12/2018
1	Scopolamine (Hyoscine)FDA Link 12/2018
1	EicosanoidsIBA 01/2018
1	neodymium pyrocatechin disulfonate (NPD)IBA 01/2017
1	Fish OilsIBA 01/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 04/2016
1	EnzymesIBA 04/2016
1	Butyric Acid (Butanoic Acid)IBA 04/2016
1	Protein Isoforms (Isoforms)IBA 04/2016
1	Glutamic Acid (Glutamate)FDA Link 04/2016
1	Tacrolimus Binding Proteins (FKBP)IBA 01/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016
1	CytokinesIBA 01/2016
1	CarbonIBA 02/2015
1	BenzodiazepinesIBA 10/2014
1	LigandsIBA 07/2014
1	Escitalopram FDA Link 11/2013
1	Bupropion (Wellbutrin)FDA LinkGeneric 09/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2013
1	Opioid Receptors (Opioid Receptor)IBA 04/2013
1	Serotonin 5-HT1 Receptor AntagonistsIBA 03/2013
1	AndrogensIBA 10/2012
1	LithiumIBA 10/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2011
1	KynurenineIBA 08/2011
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2011
1	Progesterone FDA LinkGeneric 03/2010
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2010

Therapy/Procedure

2	Aftercare (After-Treatment) 01/2021 - 06/2019
2	Drug Therapy (Chemotherapy) 01/2005 - 09/2004